0001213900-23-022878.txt : 20230324 0001213900-23-022878.hdr.sgml : 20230324 20230324180340 ACCESSION NUMBER: 0001213900-23-022878 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230322 FILED AS OF DATE: 20230324 DATE AS OF CHANGE: 20230324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COLEMAN KIRK ALLEN CENTRAL INDEX KEY: 0001790624 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39102 FILM NUMBER: 23760998 MAIL ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001733413 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824344737 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 737-802-1973 MAIL ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 ownership.xml X0407 4 2023-03-22 0 0001733413 TFF Pharmaceuticals, Inc. TFFP 0001790624 COLEMAN KIRK ALLEN 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107 0 1 0 0 Chief Financial Officer 0 Stock Options (Right to Buy) 0.80 2023-03-22 4 A 0 100000 0 A 2024-03-22 2033-03-22 Common Stock 100000 100000 D The Options are granted under TFF Pharmaceuticals, Inc. 2021 Stock Incentive Plan. The Options shall vest and first become exercisable as follows: one-quarter of the Options shall vest and first become exercisable on March 22, 2024 and the remainder of the Options shall vest and first become exercisable in 12 equal quarterly installments commencing on June 22, 2024. /s/ Kirk Allen Coleman 2023-03-24